FDA Inspection 651951 — New York Blood Center Enterprises

New York Blood Center Enterprises — FEI 2473015

The FDA completed an inspection of New York Blood Center Enterprises on Mar 23, 2010 in Rye, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 23, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Rye, NY (United States)

Citations

IDCFRDescription
135821 CFR 211.100(b)SOPs not followed / documented
1503021 CFR 606.60(b)Equipment calibration frequency

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.